Gen Pharmaceuticals
Europe, Ankara, Turkey, Ankara
Description
This company is a pharmaceutical sector with the drugs used in the treatment of rare diseases.
Investor Profile
Gen Pharmaceuticals has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, Turkey.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United States (50%)
- Turkey (50%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
